The Green Organic Dutchman Holdings Ltd.
$75 Million Bought Deal Financing
TGOD is committed to becoming the largest organic cannabis brand in the world, and the Company is on an excellent path with the additional $75 million bought deal financing announced last week. This additional capital will be used to advance the Company’s rapid and strategic international expansion plan, with the next phases of growth to focus on Europe and Latin America. With potential consumer populations of nearly 750,000,000 and 650,000,000 respectively, these markets represent a key development opportunity in the Company’s global growth plan. The Company will utilize the funds from the financing to establish strategic product manufacturing, which adheres to the Company’s proprietary organic growing principles, and robust sales and distribution capabilities across Europe and Latin America. Within these markets and beyond, TGOD will continue to invest in global cultivation opportunities and technology partnerships to deliver unique and innovative forms of its premium organic product to consumers.
International Expansion
TGOD has made substantial progress towards its goal of having operations in 12 countries on 3 continents by the end of 2018 with its recently announced investments in Jamaica and Poland, and the planned expansion in Denmark.
In Jamaica, TGOD’s partner Epican is on track to open 5 dispensaries by Q1 of 2019, including the flagship store in Kingston that opened in July. Cultivation on the Company’s newly leased land is on schedule for completion in the fourth quarter of 2018. This new site brings TGOD’s productive capacity in Jamaica to 14,000 kgs, a large portion of which will be dedicated to TGOD branded products for export to global markets.
Last week, TGOD closed the acquisition of HemPoland. Europe is home to three-quarters of a billion potential consumers, and HemPoland is a leading manufacturer and marketer of premium CBD oils within this market. This acquisition provides TGOD with access to HemPoland’s significant distribution network, state-of-the-art hemp oil extraction technology and the premium top selling Cannabigold brand. The transaction also provides immediate revenue for TGOD. The Company has also made excellent progress with its joint venture partner in Denmark, in developing R&D and cultivation capabilities. An application has been filed for a cannabis cultivation license from the Danish authorities, and approval is expected during the last quarter of 2018.
TGOD is focused on building the leading organic cannabis brand in the world, and will be bringing leading technologies to its production in Jamaica, Poland and Denmark. This will ensure TGOD’s brand has the best efficacy and product delivery for medical patients and adult use consumers across all product forms.
Facility Construction
In Canada, TGOD continues to make progress on construction in both Hamilton and Valleyfield. The facilities consist of high efficiency sites conforming to GMP standards with LEED certification. Timelines remain on schedule with cultivation beginning Q1 2019 in Hamilton, Ontario and in Q2 in Valleyfield, Quebec.
Please click here for the latest videos.
Brand Development
The Company has been working with consumers around the globe to gain valuable insights to shape the development of the TGOD brand. The response to organically-certified cannabis has been very strong across both the recreational and medicinal markets and the response to the TGOD brand name has been strong across multiple countries and languages.
Please visit the Company’s previously issued press release for a look and feel of TGOD’s premium organic cannabis brand by clicking here.
TGOD is preparing to launch a “Founders Club” to select medical patients in January 2019. The Company will then expand its product offerings to more patients during the first half of 2019, and further to recreational markets in the second half of the year. TGOD expects to have full national distribution across all provincial and territorial adult use market during 2019.
Strategic Talent Acquisition
TGOD continues to make significant progress on the buildout of its skilled leadership team with unprecedented experience in CPG and branded product, pharma and retail. Management is focused on quality of execution and being a leader in leveraging the experience of its team to shape the future path of the global cannabis industry. With the newest additions to our senior team, the Company now has over 200 years of CPG experience
The Company has also added Tim Seymour to its advisory board to assist with US strategies, including planning for a NYSE listing.
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities in Ontario, Quebec and Jamaica.
The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 millionfor 20% offtake from TGOD’s local production. In addition, TGOD has raised approximately C$350 million and has over 20,000 shareholders.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
Read Next
